Christopher J Rhodes

Whole genome sequencing of a sporadic primary immunodeficiency cohort

William J. Astle, Sri V. V. Deevi, Kenneth G. C. Smith, 2018, Nature.

Mendelian randomisation and experimental medicine approaches to interleukin-6 as a drug target in pulmonary arterial hypertension

R. Kittles, M. Humbert, L. Harbaum, 2021, European Respiratory Journal.

(cid:2) -Cell Failure in Type 2 Diabetes: Postulated Mechanisms and Prospects for Prevention and Treatment

C. Ling, K. Polonsky, L. Sussel, 2014 .

Long non-coding RNA RGMB-AS1 as a novel modulator of Bone Morphogenetic Protein Receptor 2 signaling in pulmonary arterial hypertension

M. Wilkins, M. Nicolls, Md Khadem Ali, 2022, bioRxiv.

Maternal and perinatal obesity induce bronchial obstruction and pulmonary hypertension via IL-6-FoxO1-axis in later life

J. Priest, M. Odenthal, S. Pullamsetti, 2022, Nature Communications.

A ploidy-agnostic method for estimating telomere length from whole genome sequencing data.

Ania, Eleanor, Dewhurst, 2018 .

Using the Plasma Proteome for Risk Stratifying Patients with Pulmonary Arterial Hypertension.

M. Humbert, L. Harbaum, J. Lordan, 2022, American journal of respiratory and critical care medicine.

An organ-on-chip model of pulmonary arterial hypertension identifies a BMPR2-SOX17-prostacyclin signalling axis

J. Edel, A. Fellows, K. Gray, 2022, Communications Biology.

Circulating markers of inflammation and angiogenesis and clinical outcomes across subtypes of pulmonary arterial hypertension.

N. Morrell, M. Wilkins, P. Leary, 2022, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.